Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical validation of breast cancer biomarkers using tissue microarray technology.

Iram Quraishi1, Mazhar Rishi, Michael Feldman

  • 1University of Pennsylvania Philadelphia, PA , USA. irishi@gw.mp.sc.edu

Applied Immunohistochemistry & Molecular Morphology : AIMM
|June 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Massive brain swelling after cranioplasty in the setting of severe sunken flap syndrome: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Pitch Perfect: Clinical Research Primer on the Art of Pitching Projects for Medical Students.

Journal of neurological surgery reports·2026
Same author

Patellar Tendon Reconstruction with Allograft in an Ultra-Low-Velocity Multiligamentous Knee Injury: A Case Report.

JBJS case connector·2026
Same author

Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Journal for immunotherapy of cancer·2025
Same author

DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer.

NPJ breast cancer·2025
Same author

When a model gives you mixed signals: cognitive effects and visual behavior.

Process science·2025

This study validated tissue microarray (TMA) technology for breast cancer research. Results showed prostatic-specific antigen (PSA) was not expressed in breast cancer tissues, contrary to initial DNA microarray findings, emphasizing validation importance.

Area of Science:

  • Oncology
  • Genomics
  • Pathology

Background:

  • DNA microarrays identified genes linked to breast cancer progression.
  • Evaluating these genes requires extensive immunohistochemistry on tissue blocks.
  • Tissue microarray (TMA) technology offers a method to analyze protein expression in clinical specimens.

Purpose of the Study:

  • To assess the utility of TMA for validating gene expression findings in breast cancer.
  • To investigate the expression of prostatic-specific antigen (PSA) in breast cancer progression using TMA.
  • To confirm the reliability of TMA for analyzing candidate genes in breast cancer.

Main Methods:

  • Construction of a breast cancer progression TMA with normal epithelium, ductal carcinoma in situ, invasive ductal carcinomas, and metastatic carcinomas.

Related Experiment Videos

  • Inclusion of prostatic adenocarcinoma and normal colon tissues as positive and negative controls, respectively.
  • Validation of TMA methodology using established markers (estrogen receptor, progesterone receptor, p53) followed by PSA antibody testing.

    • Main Results:

    • Established markers (ER, PR, p53) yielded results consistent with prior research, validating the TMA approach.
    • Prostatic-specific antigen (PSA) expression was negative in all 98 breast cancer tissue cores, including positive controls.
    • Initial DNA microarray data suggesting higher PSA expression in invasive ductal carcinomas was contradicted by TMA results.

    Conclusions:

    • TMA technology is a viable method for validating DNA microarray findings in breast cancer.
    • The study highlights the critical need for validation of gene expression data, particularly when findings contradict existing literature.
    • PSA is not expressed in the analyzed breast cancer tissues, underscoring the importance of rigorous validation in molecular pathology studies.